ReviewCureus2025
Cardiac Optimisation in Proximal Femoral Fractures in the Elderly.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- When the Heart and Hip Collide: The Interplay Between Atrial Fibrillation and Neck of Femur Fractures.Journal of cardiovascular development and disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fragility hip fractures are increasingly common in elderly patients and are associated with high morbidity and mortality. Cardiovascular comorbidities-including ischaemic heart disease, heart failure, and valvular disease-contribute significantly to poor outcomes. This study aimed to review perioperative cardiac complications in elderly patients undergoing fragility hip fracture repair and evaluate strategies for optimisation, with emphasis on postoperative atrial fibrillation (POAF), acute myocardial infarction (AMI), heart failure, and management of cardiac implantable electronic devices (CIEDs). We conducted a narrative review drawing data from the databases PubMed, Embase, and the Cochrane Library (January 2000-March 2024). The search terms included "hip fracture," "cardiac complications," "postoperative atrial fibrillation," "myocardial infarction," "heart failure," "valvular disease," and "cardiac implantable electronic devices." Guidelines from the National Institute for Health and Care Excellence (NICE), the European Society of Cardiology (ESC), and the American College of Cardiology/American Heart Association (ACC/AHA) were also reviewed. POAF was observed in ~3-4% of elderly hip fracture patients and is associated with significantly higher one-year mortality (60% vs. 19.5%). Risk factors include surgical delay beyond 48 hours and transfusion of >2 units of packed red blood cells. AMI and perioperative heart failure are frequently underdiagnosed due to atypical presentations. CIED management requires multidisciplinary coordination to avoid device malfunction. Cardiac optimisation in fragility hip fracture patients remains challenging due to heterogeneous evidence and variable practice. Development of validated POAF risk prediction tools, standardised treatment protocols, and structured multidisciplinary pathways may help improve outcomes and reduce healthcare burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.